Ask AI

Frontline Response in Emergency Medicine: Best Practices for Early Recognition and Management of CAR T-Cell and Bispecific Antibody–Related AEs

Enhance your ability to identify and manage adverse events associated with CAR T-cell therapies and bispecific antibodies in patients with cancer presenting to the emergency department through an expert-authored ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Activities

CRS ICANS Emergency Care
Frontline Response in Emergency Medicine: Best Practices for Early Recognition and Management of CAR T-Cell and Bispecific Antibody–Related AEs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 11, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson